Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Ruszkay, Nicole
Tucker, Jacqueline
and
Choi, Karen Y.
2022.
Otolaryngology in the face of A pandemic.
Operative Techniques in Otolaryngology-Head and Neck Surgery,
Vol. 33,
Issue. 2,
p.
74.
Jones, Kasey
Hadley, Emily
Preiss, Sandy
Lofgren, Eric T.
Rice, Donald P.
Stoner, Marie C. D.
Rhea, Sarah
and
Adams, Joëlla W.
2023.
Estimate of undetected severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in acute-care hospital settings using an individual-based microsimulation model.
Infection Control & Hospital Epidemiology,
Vol. 44,
Issue. 6,
p.
898.
Penney, Jessica A.
and
Doron, Shira
2023.
Ventilated patient headboards in the postanesthesia care unit as an alternative to universal preprocedural severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing.
Infection Control & Hospital Epidemiology,
Vol. 44,
Issue. 4,
p.
686.
Chang-Graham, Alexandra L.
Sahoo, Malaya K.
Huang, ChunHong
Solis, Daniel
Sibai, Mamdouh
August, Gianna
Calayag, Lira
Kenji, Obadia M.
Shi, Run-Zhang
Mostafa, Heba H.
Lei, Guang-Sheng
Relich, Ryan F.
and
Pinsky, Benjamin A.
2023.
Comparison of nucleocapsid antigen with strand-specific reverse-transcription PCR for monitoring SARS-CoV-2 infection.
Journal of Clinical Virology,
Vol. 164,
Issue. ,
p.
105468.
Talbot, Thomas R.
Hayden, Mary K.
Yokoe, Deborah S.
Malani, Anurag N.
Amer, Hala A.
Kalu, Ibukunoluwa C.
Logan, Latania K.
Moehring, Rebekah W.
Munoz-Price, Silvia
Palmore, Tara N.
Weber, David J.
and
Wright, Sharon B.
2023.
Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations.
Infection Control & Hospital Epidemiology,
Vol. 44,
Issue. 1,
p.
2.
Uno, Shunsuke
Goto, Rei
Honda, Kimiko
Uchida, Sho
Uwamino, Yoshifumi
Namkoong, Ho
Yoshifuji, Ayumi
Mikita, Kei
Takano, Yaoko
Matsumoto, Morio
Kitagawa, Yuko
and
Hasegawa, Naoki
2024.
Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis.
Clinical Infectious Diseases,
Vol. 78,
Issue. 1,
p.
57.